150 related articles for article (PubMed ID: 33501810)
1. [Correlation between gut microbiota and liver biochemical indicators in patients with chronic hepatitis B].
Zhao Z; Qin S; Wang L; Li L; Liu Y; Deng L; Zou Z
Sheng Wu Gong Cheng Xue Bao; 2021 Jan; 37(1):301-311. PubMed ID: 33501810
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M
Front Microbiol; 2017; 8():2222. PubMed ID: 29180991
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
6. Modulation of bile acid profile by gut microbiota in chronic hepatitis B.
Wang X; Chen L; Wang H; Cai W; Xie Q
J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
8. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection.
Yang R; Xu Y; Dai Z; Lin X; Wang H
J Immunol Res; 2018; 2018():2361963. PubMed ID: 30148173
[TBL] [Abstract][Full Text] [Related]
9. The role of gut microbiota in hepatitis B disease progression and treatment.
Chen B; Huang H; Pan CQ
J Viral Hepat; 2022 Feb; 29(2):94-106. PubMed ID: 34415656
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions.
Li YG; Yu ZJ; Li A; Ren ZG
World J Gastroenterol; 2022 Jul; 28(28):3555-3572. PubMed ID: 36161048
[TBL] [Abstract][Full Text] [Related]
11. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.
Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S
J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339
[TBL] [Abstract][Full Text] [Related]
12. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH
Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
14. [Effective antiviral therapy with entecavir in chronic hepatitis B virus carriers].
Yan C; Yao Y; Mao X
Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):900-3. PubMed ID: 25654282
[TBL] [Abstract][Full Text] [Related]
15. Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project.
Ling Z; Liu X; Cheng Y; Jiang X; Jiang H; Wang Y; Li L
Sci Rep; 2015 Nov; 5():17098. PubMed ID: 26606973
[TBL] [Abstract][Full Text] [Related]
16. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W
Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085
[TBL] [Abstract][Full Text] [Related]
17. [Long-term prognosis and quality of life of survivors with hepatitis B virus-related acute-on-chronic liver failure].
Zhu CY; Lu GT; Qi TT; He QJ; Chen YP; Wen WQ; Zhou FY; Chen JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):736-741. PubMed ID: 29997098
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial.
Chi X; Cheng DY; Sun X; Liu SA; Wang RB; Chen Q; Xing HC
Chin J Integr Med; 2023 Sep; 29(9):771-781. PubMed ID: 37222832
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
